Xarelta 2.5 mg (Tablet)
Unit Price: ৳ 8.00 (2 x 14: ৳ 224.00)
Strip Price: ৳ 112.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Rivaroxaban |
| Company | Opsonin pharma ltd |
| Also available as |
Indications
- Prevention of atherothrombotic events after an Acute Coronary Syndrome
- Stroke and systemic embolism risk reduction in nonvalvular atrial fibrillation
- Deep vein thrombosis (DVT) and pulmonary embolism (PE) treatment
- Prophylaxis of DVT in patients undergoing knee or hip replacement surgery
Pharmacology
- Highly selective direct factor Xa inhibitor
- Interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade
Dosage & Administration
- Rivaroxaban 2.5 mg recommended dose
- Rivaroxaban 10-20 mg dosage for nonvalvular atrial fibrillation
- Rivaroxaban 10-20 mg treatment dosage for DVT & PE
- Prophylaxis dosage of DVT following hip or knee replacement surgery
Interaction
- Concomitant use with P-gp and CYP3A4 inhibitors
- Concomitant use with P-gp and strong CYP3A4 inducers
- Concomitant use with anti-platelet agents, heparin, and fibrinolytic therapy
Contraindications
- Known hypersensitivity to Rivaroxaban or any excipients
- Active pathological bleeding
Side Effects
- Increased chance of bleeding
- Spinal or epidural hematoma risk
- Increased risk of stroke after discontinuation in nonvalvular atrial fibrillation
Pregnancy & Lactation
- Category C drug
- Unknown excretion in human milk
Precautions & Warnings
- Increased risk of fatal bleeding
- Monitoring for signs or symptoms of neurological impairment
- Not recommended in patients with pulmonary embolism who present with hemodynamic instability
Overdose Effects
- Hemorrhage risk
- No specific antidote available
Therapeutic Class
- Oral Anticoagulants
Storage Conditions
- Store in a cool and dry place below 30°C
- Protected from light
- Keep away from the reach of children